Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2018-01-11 Capital/Financing Update
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Vitrolife acquires licensing rights to technology for embryo transfer
Capital/Financing Update Classification · 95% confidence The document is a press release dated January 11, 2018, announcing that Vitrolife AB has acquired exclusive global licensing rights for an embryo transfer technology and intends to commercialize it. This describes a significant corporate transaction related to business operations and asset acquisition, which falls under the scope of corporate financing or strategic activity. Since it is an announcement of a specific strategic transaction (acquisition of licensing rights and associated purchase price details), it best fits the 'Capital/Financing Update' (CAP) category, as it details a change in the company's assets/rights structure and associated financial outlay. It is not a standard regulatory filing like 10-K or IR, nor is it a management change (MANG) or dividend notice (DIV). It is a specific corporate action announcement.
2018-01-11 English
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder ('The Capital Group Companies, Inc.') in the issuer ('Vitrolife AB'). It explicitly states the 'Reason for major shareholding notification Sell' and provides the 'Before the transaction' and 'After the transaction' share counts and resulting percentages (4.45%). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ' (Major Shareholding Notification). The document is not a full report, an earnings release, or a director's dealing, but a specific regulatory disclosure regarding ownership thresholds.
2017-11-13 English
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder ('William Demants og Hustru Ida Emilies Fond - kaldet Oticon-fonden') in Vitrolife AB. It explicitly states the 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage (21.59%). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific disclosure regarding ownership thresholds.
2017-11-10 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'delårsrapport' (interim report) for Vitrolife AB for the period January-September 2017. It contains detailed financial statements, segment reporting, cash flow analysis, and management commentary on performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-02 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'interim report january-September 2017' and contains detailed financial statements, segment reporting, cash flow analysis, and management commentary for the specified period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-02 English
Election committee for Vitrolife AB (publ)
AGM Information Classification · 98% confidence The document is a press release dated October 6, 2017, announcing the appointment of members to the election committee for the upcoming Annual General Meeting (AGM) scheduled for April 26, 2018. It also provides instructions for shareholders wishing to submit items for consideration at the AGM. Since the content directly relates to the preparation and governance surrounding the Annual General Meeting, the most appropriate classification is AGM Information (AGM-R). It is not the AGM presentation itself, but preparatory information related to it.
2017-10-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.